Remote monitoring for IBD patients on stable treatment
Part of Digestive system clinical trials.
This study tests whether people with inflammatory bowel disease (IBD) can be safely monitored from home instead of visiting the hospital every few months. It uses a smartphone app and home tests to check your condition, with fewer in-person visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have Crohn's disease, ulcerative colitis, or IBD type unclassified
- You speak, read, and write Dutch fluently
- You have access to a smartphone or internet to use the Mynexuzhealth app
- Your IBD treatment has been stable (or you've been on no treatment) for at least 2 years
- You are willing to do a stool test every 3 months and a blood test every year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an app that lets you check in with your IBD care team only when you need to, instead of having regular appointments. It's for people with Crohn's disease or ulcerative colitis who are doing well and have been on the same medication for at least 3 months.
This study tests if a mobile app can help manage your inflammatory bowel disease (IBD) from home. You may be eligible if you have IBD that has been active in the last two years and you are between 18 and 75 years old.
This study tests a smartphone app (SEMEIA) to help monitor people with active Crohn's disease or ulcerative colitis. It may help you track your symptoms and stay in touch with your doctor without needing as many office visits.
This Phase 4 study tests whether using the myIBDcoach smartphone app helps people with Crohn’s disease manage their care. It’s for people who are newly diagnosed or having a flare and have not used biologic medicines before.
This study aims to improve care and reduce health gaps for people with inflammatory bowel disease using text-message surveys to track symptoms and guide better disease management.
This trial tests a self-management program for people with active Crohn's disease or ulcerative colitis. It aims to improve quality of life by helping you better manage your condition.
Hear when a new Crohn Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.